BioCentury
ARTICLE | Distillery Therapeutics

Autoimmune disease; neurology

October 25, 2018 5:58 PM UTC

Mouse studies suggest a mAb against fibrin could help treat MS and AD. In a mouse model of chronic MS and two mouse models of relapsing-remitting MS (RRMS), a mAb targeting fibrin decreased paralysis ...

BCIQ Company Profiles

Gladstone Institutes

BCIQ Target Profiles

Fibrin